Retour sur lavenir.net
   CMB.TECH 15.380 € (-0,13 %)     SOFINA 278.800 € (+1,01 %)     FAGRON 23.950 € (+2,13 %)     MELEXIS 55.200 € (-1,43 %)     KBC 116.800 € (+3,73 %)     AB INBEV 75.280 € (+3,15 %)     GBL 78.800 € (+1,61 %)     ELIA GROUP 130.500 € (+1,79 %)     AGEAS 78.100 € (+3,03 %)     ACKERMANS V.HAAREN 269.800 € (+1,43 %)     GIMV 49.500 € (+0,51 %)     ECONOCOM GROUP 1.540 € (+2,67 %)     SYENSQO 77.550 € (+0,98 %)     TUBIZE-FIN 233.000 € (+2,46 %)     ARGENX SE 815.000 € (+3,32 %)     AEDIFICA 65.300 € (+1,32 %)     BPOST 1.148 € (+3,80 %)     UMICORE 18.870 € (+6,25 %)     SOLVAC 84.500 € (+1,81 %)     BEKAERT 40.650 € (-0,85 %)     PROXIMUS 6.280 € (+3,63 %)     TINC 10.440 € (+0,97 %)     CENERGY 21.580 € (-2,00 %)     AGFA-GEVAERT 0.395 € (+1,54 %)     KBC ANCORA 94.400 € (+2,50 %)     SIPEF 110.600 € (+0,36 %)     TESSENDERLO 17.620 € (+1,38 %)     BELYSSE GROUP 0.351 € (+4,46 %)     ONTEX GROUP 1.530 € (-1,80 %)     VAN DE VELDE 29.400 € (+0,34 %)     HOME INVEST BE. 18.020 € (+2,39 %)     KINEPOLIS GROUP 49.550 € (+1,75 %)     LOTUS BAKERIES 14 000.000 € (+1,89 %)     D'IETEREN GROUP 182.800 € (+3,28 %)     TITAN S.A. 48.940 € (+2,00 %)     WDP 19.380 € (+1,31 %)     CIE BOIS SAUVAGE 277.000 € (+2,21 %)     WAREHOUSES ESTATES 37.400 € (0,00 %)     ENERGYVISION 18.000 € (+0,90 %)     SOLVAY 24.260 € (+3,41 %)     BARCO 6.500 € (+1,17 %)     RETAIL ESTATES 63.600 € (+2,09 %)     OXURION 0.001 € (+33,33 %)     ONWARD MEDICAL 1.900 € (+0,53 %)     VASTNED 27.700 € (+1,84 %)     VGP 65.500 € (+3,48 %)     IBA 16.540 € (+2,73 %)     ASCENCIO 53.500 € (0,00 %)     XIOR 25.350 € (+1,40 %)     BANQUP GROUP 0.862 € (+7,75 %)     BREDERODE 101.200 € (+1,20 %)     VIOHALCO 15.180 € (+1,88 %)     NYXOAH 0.784 € (+0,51 %)     WERELDHAVE BELGIUM 50.800 € (+1,60 %)     COLRUYT 36.280 € (+2,95 %)     IMMOBEL 17.650 € (0,00 %)     RECTICEL 12.040 € (-1,15 %)     EVS 18.340 € (+1,89 %)     MONTEA 67.800 € (+1,35 %)     OPTION 3.150 € (+15,81 %)  
   ALTEN 90.250 € (+3,38 %)     PUBLICIS GROUPE SA 104.450 € (+3,26 %)     ACCOR 49.370 € (+3,24 %)     BNP PARIBAS ACT.A 91.700 € (+4,67 %)     HERMES INTL 1 372.500 € (+4,57 %)     ORANGE 15.160 € (+3,13 %)     KPN KON 4.407 € (+1,99 %)     SHELL PLC 45.640 € (-1,88 %)     LAKEFRONT BIOTHER. 29.760 € (+3,62 %)     AIR FRANCE -KLM 11.275 € (+3,87 %)     RELX 36.680 € (+3,62 %)     SCHNEIDER ELECTRIC 231.550 € (-3,42 %)     THALES 227.500 € (-2,36 %)     ADYEN 854.000 € (+3,17 %)     ASML HOLDING 1 337.600 € (-3,42 %)     MEDINCELL 28.680 € (+3,02 %)     HIGH CO 3.465 € (+1,61 %)     CSG 14.124 € (+0,30 %)     SOCIETE GENERALE 63.890 € (+3,80 %)     BIOPHYTIS 0.040 € (+54,26 %)     AIR LIQUIDE 187.360 € (+2,63 %)     TKH GROUP 49.080 € (-1,45 %)     ASM INTERNATIONAL 683.600 € (-5,06 %)     PROSUS 36.995 € (+4,89 %)     BOLLORE 3.846 € (+2,18 %)     EXOR NV 74.500 € (+1,71 %)     GECINA 65.450 € (+1,39 %)     CARREFOUR 13.455 € (+2,91 %)     SANOFI 84.100 € (+3,85 %)     EURAZEO 52.100 € (+2,66 %)     ACOMO 23.250 € (+1,53 %)     SAINT GOBAIN 72.740 € (+3,44 %)     ABN AMRO BANK N.V. 41.560 € (+4,50 %)     SIDETRADE 202.500 € (+1,76 %)     HEINEKEN 83.180 € (+2,89 %)     PHILIPS KON 27.380 € (+6,54 %)     VALBIOTIS 0.660 € (-4,35 %)     LVMH 416.250 € (+3,67 %)     KERING 191.700 € (+6,36 %)     NN GROUP 80.300 € (+3,69 %)     ARCELORMITTAL SA 55.120 € (+1,77 %)     RANDSTAD NV 41.530 € (+1,42 %)     RENAULT 28.630 € (+5,10 %)     AHOLD DEL 34.290 € (+6,62 %)     VALEO 10.975 € (+0,50 %)     TELEPERFORMANCE 82.220 € (+1,53 %)     DASSAULT SYSTEMES 25.840 € (+3,44 %)     ABIVAX 79.550 € (+0,38 %)     JCDECAUX 25.300 € (+2,02 %)     LECTRA 17.980 € (+1,70 %)     COFACE 15.860 € (+1,67 %)     BUREAU VERITAS 29.900 € (+2,57 %)     STMICROELECTRONICS 40.885 € (-5,14 %)     AIRBUS 200.100 € (+3,51 %)     TOTALENERGIES 81.570 € (-1,38 %)     STELLANTIS NV 4.159 € (+1,82 %)     VEOLIA ENVIRON. 33.790 € (+2,55 %)     UNIBAIL-RODAMCO-WE 93.780 € (+1,71 %)     ESSILORLUXOTTICA 189.100 € (+2,63 %)     VOYAGEURS DU MONDE 179.500 € (0,00 %)  
News Réglementées
20/10/2026 09:00

Original-Research: Bittium Oyj (von NuWays AG): BUY

Original-Research: Bittium Oyj - from NuWays AG

20.10.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Bittium Oyj

Company Name:Bittium Oyj
ISIN:FI0009007264
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 46
Target price on sight of:12 months
Last rating change:
Analyst:Julius Neittamo

Q3 preview: record backlog to support growth

Bittium publishes its Q3 business review on Thursday, 29 October. Q3'26e sales are seen to increase 68% yoy to € 38.9m (eCons: € 34.4m), up 6% qoq from an already exceptional quarter (Q2'26: € 36.6m). Record backlog of c. € 102m and Indra-related deliveries are seen to support Q3 growth (eNuW). The latter should carry a high operating margin and support EBITDA to reach € 12.7m, at a 32.6% margin (eCons: € 10.2m / 29.7% margin). However, the Indra licensing deal accelerates amortisation and is thus seen to lift D&A to € 5.0m in Q3 (Q2'26: € 2.0m), staying elevated for the remainder of the year and thus offsetting the margin gain. This leaves our EBIT estimate at € 7.7m with 19.8% margin (eCons: € 6.6m / 19.2% margin).

Q3 commercial newsflow centred on three events. Sweden placed its first order for Tough SDR radios for c. € 0.7m under the Nordic framework agreement, while Denmark joined the same framework. Bittium is set to win further orders in Sweden and take market share from Elbit there, in our view. Furthermore, Bittium signed an important MoU with Safran Electronics & Defense to offer tactical communications to the French Armed Forces. The MoU does not yet constitute a firm commercial agreement, but we regard it as significant for the long-term. Bittium’s agreements with Indra Sistemas, BAE Systems and now Safran show that major European OEMs recognise its competitiveness in tactical software-defined radios and IP networks.

Bittium unveiled a new business structure effective FY27. Engineering Services merges into Defense & Security, leaving two reporting segments, Defense & Security and Medical. In parallel, change negotiations at Bittium Engineering Services Ltd concluded with the termination of 22 of 120 employees, generating annual cost savings of c. € 2m from January 2027. Bittium expects restructuring costs of c. € 0.5m in H2'26.

Visibility remains excellent. The record order backlog of c. € 102m, 92% of which lies in Defense & Security, covers much of the next twelve months and underpins management’s confidence in H2'26. Bittium announced no major orders in Q3, but this does not imply weak order intake, as not every order triggers a release and defence customers often limit disclosure.

We make minor adjustments to our model. We revise down Engineering Services sales estimates for H2'26e and beyond. While the merger of the consulting business into Defense & Security only takes effect from FY27, the headcount reduction is seen to weigh on sales already in Q4'26. We also factor in the c. € 2m run-rate savings. For H2'26, EBITDA estimates move up on higher-margin Indra-related revenue, though higher D&A charges should offset the incremental profitability gain at EBIT level. Our FY26e sales of € 156m remain above guidance (€ 140-155m) and eCons (€ 153m), while our EBIT estimate of € 29.2m sits within guidance (€ 26-32m) and slightly below eCons (€ 30.3m).

Bittium enters year-end in a strong position: a record backlog, a margin-accretive Indra deal and growing OEM validation underpin the investment case. We reiterate BUY with a € 46 PT based on DCF.

You can download the research here: bittium-oyj-2026-10-20-update-en-11125
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2418432  20.10.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière